Cue Biopharma Receives $7.5M Milestone Payment From Boehringer Ingelheim - Cue Biopharma (NASDAQ:CUE)

Cue Biopharma Receives $7.5M Milestone Payment From Boehringer Ingelheim - Cue Biopharma (NASDAQ:CUE)

Cue Biopharma Inc. (NASDAQ:CUE) announced it will receive a $7.5 million preclinical milestone payment from Boehringer Ingelheim. The biopharmaceutical company is developing injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body. It is set to receive the payment following Boehringer Ingelheim’s selection and approval of its first compound for lead optimization. Cue Biopharma is also el…